Vasculitis: an update.

Vasculitis: an update.

Pokaži ostale verzije (1)

The systemic vasculitides are uncommon but serious diseases. Early recognition can be difficult because they mimic many conditions. Aggressive immunosuppression is toxic but effective; a targeted approach with biological agents may improve the outcome.

Bibliografski detalji
Glavni autor:	Luqmani, R
Format:	Journal article
Jezik:	English
Izdano:	MA Healthcare Ltd 2014

Slični predmeti

Vasculitis: an update.
od: Luqmani, R
Izdano: (2014)

Update on the classification of vasculitis.
od: Waller, R, i dr.
Izdano: (2013)

Nomenclature and classification of vasculitis - update on the ACR/EULAR diagnosis and classification of vasculitis study (DCVAS).
od: Luqmani, R, i dr.
Izdano: (2011)

Discontinuation of therapies in vasculitis.
od: Luqmani, R
Izdano: (2013)

Discontinuation of therapies in vasculitis.
od: Luqmani, R
Izdano: (2013)

Discontinuation of therapies in vasculitis.
od: Luqmani, R
Izdano: (2013)

CLASSIFICATION AND DIAGNOSIS OF VASCULITIS
od: Luqmani, R
Izdano: (2012)

Pharmacotherapy of vasculitis.
od: Chan, M, i dr.
Izdano: (2009)

Using the Birmingham vasculitis activity score (BVAS) to screen for vasculitis
od: Mukhtyar, C, i dr.
Izdano: (2008)

Disease assessment in systemic vasculitis
od: Luqmani, R
Izdano: (2004)

Evaluation of vasculitis disease activity in Europe.
od: Luqmani, R
Izdano: (2001)

NEW INSIGHTS INTO THE MANAGEMENT OF SYSTEMIC VASCULITIS
od: Luqmani, R
Izdano: (2012)

DIAGNOSIS AND ASSESSMENT OF LARGE VESSEL VASCULITIS
od: Luqmani, R
Izdano: (2011)

Outcome in systemic vasculitis.
od: Luqmani, R, i dr.
Izdano: (1998)

VITAL (Vasculitis Integrated Assessment Log) assessment of vasculitis.
od: Bacon, P, i dr.
Izdano: (1995)

Assessment of systemic vasculitis.
od: Miller, A, i dr.
Izdano: (2008)

Eular recommendations for vasculitis
od: Luqmani, R, i dr.
Izdano: (2007)

Maintenance of clinical remission in ANCA-associated vasculitis.
od: Luqmani, R
Izdano: (2013)

Treat-to-target in vasculitis: is this a sensible approach?
od: Luqmani, R
Izdano: (2012)

SP0053 Hot session: vasculitis treatment
od: Luqmani, R
Izdano: (2017)

Damage assessment in ANCA-associated vasculitis.
od: Bhamra, K, i dr.
Izdano: (2012)

Outcome in small-vessel systemic vasculitis.
od: Luqmani, R, i dr.
Izdano: (2006)

Using the Birmingham Vasculitis Activity Score (BVAS) for diagnosing vasculitis
od: Luqmani, R, i dr.
Izdano: (2009)

Opinion: Maintenance of clinical remission in ANCA-associated vasculitis
od: Luqmani, R
Izdano: (2013)

Is it possible to offer evidence-based treatment for systemic vasculitis?
od: Luqmani, R
Izdano: (2000)

Updates in ANCA-associated vasculitis
od: Carolyn Ross, i dr.
Izdano: (2022-07-01)

Mortality in systemic vasculitis: a systematic review.
od: Phillip, R, i dr.
Izdano: (2008)

Cyclophosphamide and systemic vasculitis.
od: Luqmani, R, i dr.
Izdano: (1993)

Systemic vasculitis--is it time to reclassify?
od: Watts, R, i dr.
Izdano: (2011)

Optimisation of cyclophosphamide therapy in systemic vasculitis.
od: Richmond, R, i dr.
Izdano: (1998)

Outcome measures in ANCA-associated vasculitis.
od: Suppiah, R, i dr.
Izdano: (2010)

Treatment of vasculitis in rheumatoid arthritis.
od: Luqmani, R, i dr.
Izdano: (1994)

USING THE BIRMINGHAM VASCULITIS ACTIVITY SCORE (VERSION 3) FOR DIAGNOSING VASCULITIS
od: Mukhtyar, C, i dr.
Izdano: (2009)

Cardiovascular involvement in primary systemic vasculitis.
od: Mukhtyar, C, i dr.
Izdano: (2009)

Diagnosis and assessment of systemic vasculitis.
od: McLaren, J, i dr.
Izdano: (2002)

How to diagnose and treat secondary forms of vasculitis.
od: Luqmani, R, i dr.
Izdano: (2005)

Calprotectin in systemic vasculitis
od: Pathare, S, i dr.
Izdano: (2006)

ANCA-associated vasculitis: Where can we go from here?
od: Luqmani, R
Izdano: (2010)

Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.
od: Luqmani, R, i dr.
Izdano: (1994)

Advances in the classification of primary systemic vasculitis
od: Suppiah, R, i dr.
Izdano: (2009)